欧洲有源医疗器械相关法规
欧盟医疗器械标准

欧盟为消除各成员国间的贸易壁垒,逐步建立成为一个统一的大市场,以确保人员、服务、资金和产品(如医疗器械)的自由流通。
在医疗器械领域,欧盟委员会制定了三个欧盟指令,以替代原来各成员的认可体系,使有关这类产品投放市场的规定协调一致。
这三个指令分别是:1.有源植入性医疗器械指令(AIMD,90/335/EEC),适用于心脏起搏器,可植入的胰岛素泵等有源植入性医疗器械。
AIMD于1993年1月1日生效。
过渡截止期为1994年12月31日,从1995年1月1日强制实施。
2.活体外诊断器械指令(IVD),适用于血细胞计数器,妊娠检测装置等活体外诊断用医疗器械。
该指令目前仍在起草阶段,可能于1998年末或1999年初正式实施。
3.医疗器械指令(Medical Devices Direc-tive,93/42/EEC),适用范围很广,包括除有源植入性和体外诊断器械之外的几乎所有的医疗器械,如无源性医疗器械(敷料、一次性使用产品、接触镜、血袋、导管等);以及有源性医疗器械,如核磁共振仪、超声诊断和治疗仪、输液泵等。
该指令已于1995年1月1日生效,过渡截止日期为1998年6月13日从1998年6月14日起强制执行。
上述指令规定,在指令正式实施后,只有带有CE标志的医疗器械产品才能在欧盟市场上销售。
医疗器械CE认证(Medical Devices Direc-tive,93/42/EEC)介绍MDD是目前欧洲可见到的最为全面的医疗器械方面的规定,在该指令中,共有23个条款和12个附录。
其重要部分包括在以下条款中:第1条款:本指令适用于医疗器械及其附件第第2条款:成员国必须确保投放其市场和使用的医疗器械是安全的。
第3条款:所谓“安全”的器械应满足附录1中的基本要求。
第4条款:带有CE标志的医疗器械可在欧盟自由流通。
特殊条款(附录和X)允许使用无CE标志客户定制产品及临床研究的产品。
第5条款:符合协调标准的医疗器械被认为满足基本要求。
欧盟医疗器械适用标准

欧盟医疗器械适用标准
欧盟医疗器械适用标准是指在欧盟范围内对医疗器械产品的生产和销售所必须
遵守的一系列标准和规定。
这些标准和规定旨在确保医疗器械产品的质量和安全性,以保障患者和医护人员的健康和安全。
首先,欧盟医疗器械适用标准涵盖了医疗器械产品的设计和制造。
根据欧盟的
相关法规,医疗器械产品必须符合特定的设计和制造要求,以确保其安全性和有效性。
这些要求涵盖了产品的材料选择、结构设计、生产工艺等方方面面。
只有符合这些标准的产品才能在欧盟市场上销售和使用。
其次,欧盟医疗器械适用标准还包括了对医疗器械产品的市场监管和监督。
根
据欧盟的相关法规,医疗器械产品必须通过严格的市场准入程序,获得欧盟相关机构的批准后才能在市场上销售和使用。
同时,欧盟还对医疗器械产品的生产和销售过程进行监督和检查,以确保产品的质量和安全性符合标准要求。
另外,欧盟医疗器械适用标准还涉及了对医疗器械产品的标识和包装要求。
根
据欧盟的相关法规,医疗器械产品必须在产品上标注清晰的标识信息,包括产品的名称、型号、生产商信息、生产日期等内容。
同时,产品的包装必须符合相关标准要求,以确保产品在运输和存储过程中不受损,保持产品的质量和安全性。
总的来说,欧盟医疗器械适用标准是欧盟对医疗器械产品质量和安全性的保障
措施,是医疗器械生产和销售必须遵守的规定。
遵守这些标准不仅有助于保护患者和医护人员的健康和安全,也有助于医疗器械生产企业提升产品质量和竞争力。
因此,对于生产和销售医疗器械产品的企业来说,严格遵守欧盟医疗器械适用标准是非常重要的。
欧盟对医疗器械的法规要求及分类标准

D
02 欧盟医疗器械法规概述
医疗器械指令(MDD)
01
MDD是欧盟针对医疗器械的基本法规,规定了医疗器 械的定义、分类、基本要求、评估程序和市场监管等内 容。
02
MDD要求医疗器械必须符合安全性和性能的基本要求 ,并通过相应的符合性评估程序获得CE标志,才能在欧 盟市场销售和使用。
03
MDD还规定了医疗器械制造商、进口商和经销商的责 任和义务,包括建立质量管理体系、进行临床评估、报 告不良事件等。
体外诊断医疗器械法规(IVDR)
IVDR对体外诊断医疗器械的分类更加详细,要求制 造商提供更多的临床数据和性能评估报告,证明产品 的准确性和可靠性。
IVDR是欧盟针对体外诊断医疗器械的法规,于2017 年发布,2022年5月起强制执行。
IVDR还要求制造商建立严格的质量管理体系和生产 过程控制,确保产品的稳定性和一致性。同时, IVDR还规定了更加严格的市场监管措施,包括加强 不良事件报告和召回制度等。
技术文档应包括医疗器械的设计 、制造、性能、安全性、有效性 等方面的详细信息,以及相关的
试验、验证和评估结果。
技术文档应随时可供欧盟监管机 构检查,并应随着医疗器械的更
新和改进而不断更新。
上市后监管义务
制造商应对其已上市的医疗器械进行持 续的监管,以确保其在使用过程中的安
全性和有效性。
制造商应建立上市后监管计划,包括定 期收集和分析医疗器械的使用数据、不 良事件报告等信息,以及采取必要的纠
临床试验要求
对于高风险医疗器械,欧盟要求 进行临床试验以验证其安全性和
有效性。
临床试验必须在欧盟境内进行, 并符合欧盟相关法规和标准的要
求。
申请临床试验需要提交试验方案 、研究者资质、伦理委员会批准 等文件,并接受监管机构的审核
关于医疗器械的法律法规

关于医疗器械的法律法规医疗器械是指用于预防、诊断、治疗、缓解人体疾病、损伤或生理缺陷的设备、仪器、器具、材料或其他物品。
医疗器械的使用涉及人体健康和生命安全,为保障公众利益和社会秩序,各国都制定了相应的法律法规来规范医疗器械的研发、生产、流通、使用和监管等各个环节。
本文将介绍一些国内外的医疗器械法律法规,并对其中涉及的重要内容进行分析和解读。
一、国际医疗器械法律法规1. 《欧洲医疗器械指令》(Medical Device Directives)是欧洲联盟对医疗器械的法规,其中包括93/42/EEC号指令、90/385/EEC号指令和98/79/EC号指令。
这些指令主要规定了医疗器械的分类、生产许可、质量控制、技术要求、标识和说明、市场准入、市场监督等方面的内容。
2. 美国FDA(美国食品药品监督管理局)对医疗器械的管理主要基于《美国联邦食品、药品和化妆品法案》(Federal Food, Drug, and Cosmetic Act),该法案授权FDA对医疗器械的研发、生产、流通、使用和监管等进行监督和管理。
此外,美国还制定了其他相关法规,如《医疗器械分类系统》(Medical Device Classification System)和《医疗器械报告法案》(Medical Device Reporting)等。
3. 日本的医疗器械法律法规主要包括《医疗器械法》(Pharmaceutical Affairs Law)和《医疗器械安全管理法》(Act on the Safety of Medical Devices)。
这些法规规定了医疗器械的分类、许可、技术评价、标识和说明、市场监管、事故报告等方面的内容。
二、中国医疗器械法律法规1. 《中华人民共和国医疗器械管理条例》于2014年6月1日实施,是我国医疗器械管理的基本法规。
该条例规定了医疗器械的分类、质量控制、生产许可、经营许可、卫生许可、技术服务、市场监管、进出口等方面的内容。
mdd和mdr的条款

MDD和MDR的条款一、引言随着医疗技术的快速发展和全球化进程的加速,医疗器械在医疗保健领域中的作用日益突出。
医疗器械的监管要求也随之变得严格和复杂。
欧洲联盟(EU)对医疗器械实施了医疗器械指令(MDD)和医疗器械法规(MDR),以确保医疗器械的安全性和有效性。
本文将深入探讨MDD和MDR的主要条款、特点和差异,以帮助医疗器械制造商、供应商和用户更好地理解和遵守相关法规。
二、MDD和MDR概述MDD是欧盟关于医疗器械的基本法规,于1993年正式实施,并进行了多次修订。
MDD的主要目的是确保医疗器械在上市时具有足够的性能和安全性,为患者提供可靠的治疗。
MDR是欧盟最新的医疗器械法规,于2017年正式实施,取代了MDD。
MDR旨在确保医疗器械在整个生命周期内都符合高标准的安全性和有效性要求,并加强了对医疗器械的监管。
三、MDD的主要条款MDD的主要条款包括以下几个方面:1.医疗器械的定义和分类:MDD明确了医疗器械的定义,并将医疗器械分为不同类别,以便对不同类型的医疗器械实施不同的监管要求。
2.符合性评估:MDD要求医疗器械必须通过符合性评估程序才能上市销售。
符合性评估机构必须是欧盟授权的公告机构之一。
3.CE认证:为了满足MDD的要求,医疗器械必须获得CE认证标志,证明其符合相关指令的要求。
CE认证标志是欧盟产品安全性的象征。
4.上市后监督:MDD要求制造商对已上市的医疗器械进行持续监督,以确保其安全性和有效性。
制造商必须建立有效的追溯系统,以便对医疗器械进行召回和追溯。
5.临床数据和性能评估:MDD要求制造商提供充分的临床数据和性能评估报告,以证明医疗器械的有效性和安全性。
四、MDR的主要特点与变化与MDD相比,MDR的主要特点与变化包括以下几个方面:1.范围扩大:MDR扩大了监管范围,涵盖了所有类型的医疗器械,包括体外诊断医疗器械、有源植入式医疗器械等。
2.全生命周期监管:MDR要求对医疗器械进行全生命周期监管,从研发、生产、上市到退役等各个环节都必须符合相关要求。
欧盟医疗器械法规

欧盟医疗器械法规欧盟医疗器械法规是根据欧盟指令(93/42/EEC)及其修正案制定的一系列实施性立法,旨在通过各种质量管理措施,以及针对医疗器械的适用管理、生产管理和储存管理等法规,确保市场上使用的医疗器械符合最高安全标准。
本法规的范畴,主要集中在对器械实行跟踪检验、特定检验条件、质量控制、全面安全管理体系、资质证明、包装、灭菌和标贴等内容。
1. 设计和制造人员要求欧盟医疗器械法规要求,设计和制造的医疗器械须准备并保留由经认证的技术小组审核、核实和认可的文件,提供有关设计和制造过程的足够详细信息,不可删减与医疗器械本质有关的信息。
2. 医疗器械类别划分根据欧盟医疗器械法规,医疗器械分为三级,分别为备受严格控制的类(I)、控制的类(IIa、IIb)和非强制控制的类(Ⅲ)。
备受严格控制的类(I),主要用于治疗关健器官;控制类(IIa、IIb)的器械,既要求其应用安全可靠,还要考虑其潜在致病及意外结果的可能性;而非强制控制的类(Ⅲ)则可能包括治疗性外科器械、牙科器械、美容器械等。
3. 文件管理根据欧盟医疗器械法规,应当向欧盟委员会报告,对涉及可能影响患者安全危险的产品,必须记录成文的进行处理,納入完整的定期管理提示。
4. 报告要求根据欧盟医疗器械法规,厂商须必须接收及处理医疗器械使用中出现的可能危险性事件、不良事件报告及对不良事件报告做出回应,并及时向欧盟委员会、国家政府机构及其他相关机构报告。
5. 产品安全认证根据欧盟医疗器械法规,凡在欧盟地区准备上市的医疗器械,皆受到认证、检验以及报告的监管,认证和检验的依据是欧盟的安全标准及制造单位的质量管理体系。
6. 强制性认证欧盟出口等类别的医疗器械须经过某种形式的型式认证或强制性认证,而申请欧盟出口等类别的医疗器械惟有经过强制性认证,才可以进行销售;同时,向安全性要求较高的市场(如美国、加拿大等)出口医疗器械亦需要经过强制性认证。
欧洲医疗器械法规概述

法规鼓励医疗器械创新,推动欧洲医疗器械行业的持续发展。
提高国际竞争力
统一的欧洲医疗器械市场准入标准,有助于提高欧洲医疗器械的 国际竞争力。
未来发展趋势及挑战分析
法规不断更新完善
随着科技的不断进步和医疗需求的不断变化,欧洲医疗器械法规将 不断更新完善。
监管要求更加严格
未来欧洲医疗器械市场的监管要求将更加严格,企业需要加强合规 意识。
THANKS
感谢观看
遵守法规可以提高企业的信誉度,增 强消费者对企业的信任感。
02
医疗器械分类与监管要求
医疗器械分类标准
风险等级
根据医疗器械的潜在风险,将其 分为I类、IIa类、IIb类和III类,风
险等级依次递增。
用途和功能
考虑医疗器械的用途、功能、侵入 性等因素进行分类。
技术特性
涉及医疗器械的技术复杂性、创新 性等因素。
关注欧洲医疗器械法规的最新动态和 变化,以便及时调整企业的经营策略 。
了解不同类别医疗器械的认证流程和 要求,为产品选择合适的认证路径。
建立完善的质量管理体系并持续改进
建立符合欧洲医疗器械法规要 求的质量管理体系,确保产品 的质量和安全性。
定期对质量管理体系进行内部 审核和外部审计,及时发现并 纠正存在的问题。
建立完善的知识产权管理体系,加强知识产权的保护和管 理。
应对侵权行为
发现侵权行为时,需要积极采取措施予以应对,包括向相 关部门投诉、寻求法律援助等。
05
企业合规经营策略与建议
深入了解欧洲医疗器械法规要求
仔细研究欧洲医疗器械指令(MDD) 和欧洲医疗器械法规(MDR)的具体 要求,确保产品符合相关法规标准。
最新法规
欧盟医疗器械法规概述

通过制定统一的法规和标准,欧盟医疗器械法规 旨在促进医疗器械的创新和发展,推动欧洲医疗 器械产业的竞争力。
协调成员国之间的法规差异
欧盟医疗器械法规致力于协调各成员国之间的法 规差异,确保医疗器械在欧盟内部市场的自由流 通。
法规概述的范围
医疗器械的定义和分类
欧盟医疗器械法规明确了医疗 器械的定义,并根据其风险等 级进行分类,包括Ⅰ类、Ⅱa 类、Ⅱb类和Ⅲ类医疗器械。
指定机构参与
注册与备案流程
制造商需向所在成员国的竞争主管机 构提交注册申请,获得CE标志并完成 相关备案手续后,方可在欧盟市场销 售。
涉及高风险类别的医疗器械,需由指 定的欧盟认证机构进行评估和批准。
生产现场的监督检查
要点一
通知与现场检查
成员国竞争主管机构可对制造商的生 产现场进行通知或未通知的监督检查 ,以确保生产质量管理体系的有效运 行。
医疗器械指令
MDD 93/42/EEC
这是旧的欧盟医疗器械指令,自 1993年起实施。虽然它已被MDR取 代,但在一定过渡期内,仍有一些医 疗器械在该指令下受到监管。
AIMDD 90/385/EEC
这是关于有源植入式医疗器械的指令 ,它规定了这类高风险医疗器械的特 殊要求。
体外诊断医疗器械指令
IVDD 98/79/EC
此外,随着人工智能、大数据等技术的不断发展,欧盟医疗器械法规也将积极探索 和应用这些新技术,提高监管效率和透明度。
THANKS
感谢观看
I类医疗器械
建立技术文件,进行CE自我声明,加贴CE标志。
IIa、IIb、III类医疗器械
需向指定机构申请CE认证,通过审核后获得CE证书,加贴CE标志。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
COMMISSION REGULATION (EU) No 207/2012of 9 March 2012on electronic instructions for use of medical devices(Text with EEA relevance)THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the EuropeanUnion,Having regard to Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices ( 1 ), and in particular Article 9(10) thereof,Having regard to Council Directive 93/42/EEC of 14 June 1993 concerning medical devices ( 2 ), and in particular Article 11(14) thereof, Whereas:(1) For some medical devices the provision of instructionsfor use in electronic form instead of in paper form can be beneficial for professional users. It can reduce the environmental burden and improve the competitiveness of the medical devices industry by reducing costs, while maintaining or improving the level of safety.(2) Such possibility of providing instructions for use in elec tronic form instead of in paper form should be limited to certain medical devices and accessories intended to be used in specific conditions. In any case, for reasons of safety and efficiency users should always have the possi bility to obtain those instructions for use in paper form on request.(3)In order to reduce potential risks as far as possible, theappropriateness of the provision of instructions for use in electronic form should be subject to a specific risk assessment by the manufacturer.(4)In order to ensure that users have access to the instructions for use, appropriate information about access to those instructions for use in electronic form and about the right to request the instructions for use in paper form, should be provided.(5) To ensure unconditional access to the instructions for usein electronic form and to facilitate the communication of updates and of product alerts, the instructions for use in electronic form should also be available through a website.(6) Regardless of the language obligations imposed onmanufacturers by the law of the Member States, manu facturers who provide instructions for use in electronic form should indicate on their website in which Union languages those instructions are available.(7) Except for medical devices of Class I, as defined in AnnexIX to Directive 93/42/EEC, the fulfilment of theobligations laid down in this Regulation should bereviewed by a notified body during the procedure applicable for conformity assessment based on a specific sampling method.(8) As the protection of the right to privacy of naturalpersons with respect to the processing of personal datashould be ensured by manufacturers and notified bodies as well, it is appropriate to provide that websites containing instructions for use of a medical device fulfil the requirements of Directive 95/46/EC of the European Parliament and of the Council of 24 October 1995 on the protection of individuals with regard to the processing of personal data and on the free movement of such data ( 3 ).(9) In order to ensure safety and consistency, instructions foruse in electronic form which are provided in addition tocomplete instructions for use in paper form should be covered by this Regulation as regards limited requirements in relation to their contents and websites.(10) It is appropriate to provide for a deferred application ofthis Regulation so as to facilitate the smooth transition tothe new system and to allow all operators and Member States time to adapt to it.(11) The measures provided for in this Regulation are inaccordance with the opinion of the Committee set up by Article 6(2) of Directive 90/385/EEC,HAS ADOPTED THIS REGULATION:Article 1This Regulation establishes the conditions under which the instructions for use of medical devices referred to in point 15 of Annex 1 to Directive 90/385/EEC and in point 13 of Annex I to Directive 93/42/EEC may be provided in electronic form instead of in paper form.It also establishes certain requirements concerning instructions for use in electronic form which are provided in addition to complete instructions for use in paper form relating to their contents and websites.Article 2For the purposes of this Regulation, the following definitions shall apply:(a) ‘instructions for use’ means information provided by themanufacturer to inform the user of the device of its safe and proper use, of its expected performances and of any( 1 ) OJ L 189, 20.7.1990, p. 17. ( 2 ) OJ L 169, 12.7.1993, p. 1.( 3 ) OJ L 281, 23.11.1995, p. 31.precautions to be taken as outlined in the relevant parts of point 15 of Annex 1 to Directive 90/385/EEC and of point13 of Annex I to Directive 93/42/EEC;(b) ‘instructions for use in electronic form’ means instructionsfor use displayed in electronic form by the device, contained in portable electronic storage media supplied by the manufacturer together with the device, or instructions for use available through a website;(c) ‘professional users’ means persons using the medical devicein the course of their work and in the framework of a professional healthcare activity;(d) ‘fixed installed medical devices’ means devices and theiraccessories which are intended to be installed, fastened or otherwise secured at a specific location in a healthcare facility so that they cannot be moved from this location or detached without using tools or apparatus, and which are not specifically intended to be used within a mobile healthcare facility.Article 31. Subject to the conditions set out in paragraph 2, manufacturers may provide instructions for use in electronic form instead of in paper form where those instructions relate to any of the following devices:(a) active implantable medical devices and their accessoriescovered by Directive 90/385/EEC intended to be used exclusively for the implantation or programming of a defined active implantable medical device;(b) implantable medical devices and their accessories covered byDirective 93/42/EEC intended to be used exclusively for the implantation of a defined implantable medical device;(c) fixed installed medical devices covered by Directive93/42/EEC;(d) medical devices and their accessories covered by Directives90/385/EEC and 93/42/EEC fitted with a built-in system visually displaying the instructions for use;(e) stand-alone software covered by Directive 93/42/EEC.2. Manufacturers may provide instructions for use in electronic form instead of in paper form for the devices listed in paragraph 1 under the following conditions:(a) the devices and accessories are intended for exclusive use byprofessional users;(b) the use by other persons is not reasonably foreseeable.Article 41. Manufacturers of devices referred to in Article 3 that provide instructions for use in electronic form instead of in paper form shall undertake a documented risk assessment which shall cover at least the following elements:(a) knowledge and experience of the intended users inparticular regarding the use of the device and user needs;(b) characteristics of the environment in which the device willbe used;(c) knowledge and experience of the intended user of thehardware and software needed to display the instructions for use in electronic form;(d) access of the user to the reasonably foreseeable electronicresources needed at the time of use;(e) performance of safeguards to ensure that the electronic dataand content are protected from tampering;(f) safety and back-up mechanisms in the event of a hardwareor software fault, particularly if the instructions for use in electronic form are integrated within the device;(g) foreseeable medical emergency situations requiring theprovision of information in paper form;(h) impact caused by the temporary unavailability of thespecific website or of the Internet in general, or of their access in the healthcare facility as well as the safety measures available to cope with such a situation;(i) evaluation of the time period within which the instructionsfor use shall be provided in paper form at the users request.2. The risk assessment for the provision of the instructions for use in electronic form shall be updated in view of the experience gained in the post-marketing phase.Article 5Manufacturers of devices referred to in Article 3 may provide instructions for use in electronic form instead of in paper form under the following conditions:(1) the risk assessment referred to in Article 4 shall demonstrate that providing instructions for use in electronic formmaintains or improves the level of safety obtained byproviding the instructions for use in paper form;(2) they shall provide instructions for use in electronic form inall Member States where the product is made available orput into service, unless duly justified in the risk assessmentreferred to in Article 4;(3) they shall have a system in place to provide theinstructions for use in printed paper form at no additionalcost for the user, within the time period set out in the riskassessment referred to in Article 4 and at the latest within7 calendar days of receiving a request from the user or atthe time of delivery of the device if so requested at thetime of order;(4) they shall provide, on the device or on a leaflet,information on foreseeable medical emergency situationsand, for devices fitted with a built-in system visuallydisplaying the instructions for use, information on howto start the device;(5) they shall ensure the proper design and functioning of theinstructions for use in electronic form and provide verification and validation evidence to this effect;(6) for medical devices fitted with a built-in system visuallydisplaying the instructions for use, they shall ensure thatdisplaying the instructions for use does not impede thesafe use of the device, in particular life-monitoring orlife-supporting functions;(7) they shall provide, in their catalogue or in other appropriate device information support, information on softwareand hardware requirements needed to display the instructions for use;(8) they shall have a system in place to clearly indicate whenthe instructions for use have been revised and to informeach user of the device thereof if the revision wasnecessary for safety reasons;(9) for devices with a defined expiry date, except implantabledevices, they shall keep the instructions for use availablefor the users in electronic form for at least 2 years afterthe end of the expiry date of the last produced device;(10) for devices without a defined expiry date and forimplantable devices, they shall keep the instructions foruse available for the users in electronic form for aperiod of 15 years after the last device has been manufactured.Article 61. Manufacturers shall clearly indicate that the instructions for use of the device are supplied in electronic form instead of in paper form.That information shall be provided on the packaging for each unit or, where appropriate, on the sales packaging. In the case of fixed installed medical devices, that information shall also be provided on the device itself.2. Manufacturersshall provide information on how to access the instructions for use in electronic form. That information shall be provided as set out in the second subparagraph of paragraph 1 or, if not practicable, in a paper document supplied with each device.3. The information on how to access the instructions for use in electronic form shall contain the following:(a) any information needed to view the instructions for use;(b) a unique reference, giving direct access, and any otherinformation needed by the user to identify and access the appropriate instructions for use;(c) relevant manufacturer contact details;(d) where, how and within which time instructions for use inpaper form can be requested and shall be obtained at no additional cost in conformity with Article 5.4. Where a part of the instructions for use is intended to be provided to the patient, that part shall not be provided in electronic form.5. The instructions for use in electronic form shall be available entirely as text which may contain symbols and graphics with at least the same information as the instructions for use in paper form. Video or audio files may be offered in addition to the text.Article 71. Where manufacturers provide the instructions for use in electronic form on an electronic storage medium together with the device or where the device itself is fitted with a built-in system visually displaying the instructions for use, the instructions for use in electronic form shall also be made accessible to the users through a website.2. Any website containing instructions for use of a device which are provided in electronic form instead of in paper form shall comply with the following requirements:(a) the instructions for use shall be provided in a commonlyused format that can be read with freely available software;(b) it shall be protected against hardware and softwareintrusion;(c) it shall be provided in such a way that the server downtimeand display errors are reduced as far as possible;(d) it shall mention in which Union languages the manufacturerprovides the instructions for use in electronic form;(e) it shall fulfil the requirements of Directive 95/46/EC;(f) the Internet address as displayed in accordance withArticle 6(2) shall be stable and directly accessible during the periods set out in points (9) and (10) of Article 5;(g) all previous versions of the instructions for use issued inelectronic form and their date of publication shall be available on the website.Article 8Except for medical devices of Class I, as defined in Annex IX to Directive 93/42/EEC, the fulfilment of the obligations laid down in Articles 4 to 7 of this Regulation shall be reviewed by a notified body during the procedure applicable for conformity assessment as referred to in Article 9 of Directive 90/385/EEC or Article 11 of Directive 93/42/EEC. The review shall be based on a specific sampling method adapted to the class and the complexity of the product.Article 9Instructions for use in electronic form which are provided in addition to complete instructions for use in paper form shall be consistent with the content of the instructions for use in paper form.Where such instructions for use are provided through a website, this website shall fulfil the requirements set out in points (b), (e) and (g) of paragraph 2 of Article 7.Article 10This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.It shall apply from 1 March 2013.This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 9 March 2012.For the CommissionThe PresidentJosé Manuel BARROSO。